Literature DB >> 30216111

β-Arrestin1 enhances liver fibrosis through autophagy-mediated Snail signaling.

Siwei Tan1,2, Yu Lu1,2, Minyi Xu1, Xiaoli Huang1, Huiling Liu1, Jie Jiang1, Bin Wu1,2.   

Abstract

GPCR mediator β-arrestins (β-arr1 and β-arr2) regulate a variety of physiologic and pathologic processes, including hepatocellular carcinogenesis. However, the role of β-arrestins in liver fibrosis remains unknown. β-arr1, but not β-arr2, was upregulated in liver fibrotic tissues in both humans and mice; moreover, autophagy was increased. β-arr1 deficiency or autophagic inhibitor 3-methyladenine (3-MA) significantly blocked autophagy and downregulated liver fibrosis. Furthermore, β-arr1 enhanced hepatocyte compensatory proliferation, and hepatic stellate cell growth with activation via autophagy resulted in liver fibrosis. In the fibrosis, β-arr1 promoted nuclear translocation of Snail by downregulation of glycogen synthase kinase-3β, and the nuclear translocation of Snail was abrogated either by β-arr1 deficiency or by 3-MA. These results suggest that β-arr1 promotes liver fibrosis via autophagy-mediated Snail signaling, and β-arr1 may be a therapeutic target for liver fibrosis.-Tan, S., Lu, Y., Xu, M., Huang, X., Liu, H., Jiang, J., Wu, B. β-Arrestin1 enhances liver fibrosis through autophagy-mediated Snail signaling.

Entities:  

Keywords:  GSK-3β; activation; hepatic stellate cells; hepatocytes; proliferation

Mesh:

Substances:

Year:  2018        PMID: 30216111     DOI: 10.1096/fj.201800828RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor/β-arrestin1/Akt pathway.

Authors:  Siwei Tan; Huiling Liu; Bilun Ke; Jie Jiang; Bin Wu
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

2.  FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation.

Authors:  Pei-Xin Hu; Mei-Yan Sheng; Yan-Ping Liu; Chun-Qing Zhang
Journal:  Hum Cell       Date:  2022-08-05       Impact factor: 4.374

3.  Hypoxia induces the activation of hepatic stellate cells through the PVT1-miR-152-ATG14 signaling pathway.

Authors:  Fujun Yu; Buyuan Dong; Peihong Dong; Yanghuan He; Jianjian Zheng; Ping Xu
Journal:  Mol Cell Biochem       Date:  2019-12-21       Impact factor: 3.396

4.  RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.

Authors:  Zili Zhang; Mei Guo; Yujia Li; Min Shen; Desong Kong; Jiangjuan Shao; Hai Ding; Shanzhong Tan; Anping Chen; Feng Zhang; Shizhong Zheng
Journal:  Autophagy       Date:  2019-11-11       Impact factor: 16.016

5.  HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G1/S cycle.

Authors:  Yiming Lei; Xuan Xu; Huiling Liu; Lingjun Chen; Haoxiong Zhou; Jie Jiang; Yidong Yang; Bin Wu
Journal:  Autophagy       Date:  2021-04-27       Impact factor: 13.391

6.  Reply to Schierwagen et al.: β-Arrestins in liver disease.

Authors:  Songling Liu; Louis M Luttrell; Richard T Premont; Don C Rockey
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-03       Impact factor: 12.779

Review 7.  Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.

Authors:  Yajing Li; Runping Liu; Jianzhi Wu; Xiaojiaoyang Li
Journal:  Theranostics       Date:  2020-06-29       Impact factor: 11.556

8.  Fas/FasL mediates NF-κBp65/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis.

Authors:  Siwei Tan; Xianzhi Liu; Lingjun Chen; Xiaoqin Wu; Li Tao; Xuemei Pan; Shuyan Tan; Huiling Liu; Jie Jiang; Bin Wu
Journal:  Cell Death Dis       Date:  2021-05-12       Impact factor: 8.469

Review 9.  Autophagy plays a double-edged sword role in liver diseases.

Authors:  Jing-Chao Zhou; Jing-Lin Wang; Hao-Zhen Ren; Xiao-Lei Shi
Journal:  J Physiol Biochem       Date:  2021-10-18       Impact factor: 4.158

10.  Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS.

Authors:  Ming Qiao; Jianhua Yang; Yao Zhao; Yi Zhu; Xiaomei Wang; Xinling Wang; Junping Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.